UPDATE 1-Isotope supplier Nordion to go private in $727 mln deal

Fri Mar 28, 2014 6:41pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(Adds details from statement and comments from analyst and CEOs of Nordion and Sterigenics)

March 28 (Reuters) - Sterigenics, a sterilization services provider owned by private equity firm GTCR LLC, will buy Canadian medical isotopes supplier Nordion Inc for $727 million.

The offer of $11.75 per share represents a 12 percent premium to Nordion's closing price on the New York Stock Exchange on Thursday, the companies said.

"That's basically what our fair value was (for Nordion), so we think they're getting a fair price," Morningstar analyst David Krempa said.

Nordion's U.S.-listed stock trades at 8.3 times forward earnings, a slight discount to the sector median of 11.4.

Nordion is one of the world's leading producers of molybdenum-99, an isotope used in medical imaging, and the company depends on raw material from an ageing Atomic Energy of Canada Ltd (AECL) facility in Chalk River, Ontario.

A medical isotope is a radioactive substance used mainly to diagnose illness.

The Canadian government said earlier on Friday it would remove the 25-percent foreign investment cap on Nordion in cases that are deemed to be of net benefit to Canada, under legislation introduced on Friday.

Spokespersons for Industry Minister James Moore, who would have to approve the purchase for it to go forward, did not immediately respond to queries as to whether Moore knew of Sterigenics' interest before the bill was introduced or whether he considered its takeover was of net benefit to Canada.   Continued...